Table 6.
Risk Factors associated with Myalgia.
| No myalgia | Myalgia | P value (no. of observations) | OR (95% CI) unadjusted | OR (95% CI) adjusted | |
|---|---|---|---|---|---|
| Agea | 64 (50–76) | 60 (50–64) | 0.09 (366) | ||
| Sex male | 158 (76.7%) | 48 (23.3%) | 0.13 (366) | ||
| Ethnic -White | 94 (80.3%) | 23 (19.7%) | ns (308) | ||
| Ethic - Black | 52 (80%) | 13 (20%) | ns (308) | ||
| Ethnic -Asian | 46 (76.7%) | 14 (23.3%) | ns (308) | ||
| Ethnic - other | 56 (84.6%) | 10 (15.2%) | ns (308) | ||
| BMIa | 27.5 (23.7–31.2) | 26.5 (23.6–32.4) | 0.53 (317) | ||
| Admitted to ICU | 49 (16.9%) | 34 (45%) | <0.001* (366) | 4.1 (2.36–7.1) | |
| Intubated | 29 (10%) | 30 (40%) | <0.001* (336) | 6.0 (3.3–10.94) | 2.49 (1.16–5.35) [3] |
| Duration intubated (days)a | 12 (7–26) | 35 (15–48) | 0.008* | ||
| Minimum Lymphocytesa(109/L) | 0.7 (0.5–1.0) | 0.7 (0.5–0.9) | 0.47 (366) | ||
| Peak WBCa(109/L) | 9.4 (7–13.4) | 12.2 (8.5–19.8) | 0.001* (366) | 2.79 (1.6–4.7)b | 1.79 (0.92–3.49) [3] |
| Peak CRPa (mg/L) | 131 (73–214) | 181 (83–302) | 0.008* (366) | ||
| Peak ferritina (μg/L) | 961.5 (491–1564) | 1053.5 (602–2432) | 0.26 (145) | ||
| Peak D-Dimera (ng/ml) | 671 (312–2997) | 1987.5 (553–3979) | 0.025* (145) | ||
| High Risk Inpatient CXR | 107 (44.6%) | 53 (76.8%) | <0.001* (309) | 4.12 (2.23–7.61) | 2.64 (1.33–5.24) [3] |
Data presented as Frequency (%) compared using Chi square test except.
a
Median (interquartile range) compared using Mann-Whitney U test * significant.
b
Unadjusted OR for peak WBC >11 × 109/L, 3Adjusted for invasive ventilation, Peak WBC count and high risk CXR during COVID-19 admission.